drugset / Trial / NCT00002907
Bryostatin 1 in Treating Patients With Relapsed Multiple Myeloma
Treatment
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Phase II trial to study the effectiveness of bryostatin 1 in treating patients with relapsed multiple myeloma.
Timeline
- Start
- 1997-01
- Primary completion
- 1999-01
- Completion
- 2000-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | bryostatin 1 | Small molecule | — | Other |